Clinical trials continue to be a driving force in ophthalmology, propelling the development of innovative treatments and technologies that improve patient outcomes.
As the field evolves, the need for more practices to participate in research becomes greater. A search of “eye diseases” in the ClinicalTrials.gov database currently lists more than 14,700 trials total. The global ophthalmology market size was $77.1 billion in 2024 and is anticipated to reach around $144.04 billion by 2034. The North America ophthalmology market size accounted for $34.82 billion in 2024 and is anticipated to grow